MedPath

Early degeneration of the bioprothesis after catheter-assisted aortic valve implantation (TAVI)

Conditions
I35.0
Aortic (valve) stenosis
Registration Number
DRKS00026795
Lead Sponsor
Med. Klinik II - Kardiologie und AngiologieBerufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
105
Inclusion Criteria

patients with symptomatic, severe Aortic stenosis
and indication for TF-TAVI-procedure

patients agreement

Exclusion Criteria

excluding criteria for TAVI-procedure

inflammatory bowel diseases

pre-existing coagulopathy

pre-existing autoimmune disease

chronic diseases of the hematopoietic system

serum-creatinine level >2,0mg/dl (except patients with chronic kidney disease under dialysis)

hyperthyroidism

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
identification of pro-cogulatory and pro-inflammatory processes that lead to an early valve degeneration
Secondary Outcome Measures
NameTimeMethod
Changes of the microbioma as an expression of the remodeling of the intestinal biotope
© Copyright 2025. All Rights Reserved by MedPath